Remus Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0O5T01011
  • NSEID: REMUS
  • BSEID:
INR
719.95
4.2 (0.59%)
BSENSE

Dec 18

BSE+NSE Vol: 2100

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Remus Pharmaceuticals Ltd stock-summary
stock-summary
Remus Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Remus Pharmaceuticals Limited was originally incorporated as `Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat. Subsequently, Company converted from a Private to Public and the name of the Company was changed to "Remus Pharmaceuticals Limited" on January 06, 2023 by the Registrar of Companies, Ahmedabad.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 11.78 Cr
Number of Shares
1.18 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
04-Jul-2025
1.18
11.78
5892000
10
Bonus Issue
06-Jun-2024
58.92
5.89
4419000
10
Bonus Issue
26-May-2023
14.73
1.47
388000
10
Public Issue
30-Dec-2022
10.85
1.08
85000
10
Preferential basis
28-Mar-2022
1
1.00
990000
10
Bonus Issue
21-Sep-2015
1
0.01
10000
10
Subscriber to MOA
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 3 FIIs (5.02%)

Promoter with highest holding

Shah Arpit Deepakkumar (17.65%)

Highest Public shareholder

India Emerging Giants Fund Limited (4.76%)

Individual Investors Holdings

18.78%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR Cr (Micro Cap)

stock-summary
P/E

29.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00